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Abstract
Introduction: Oedematous lesions are a less common but more severe form of Mycobacterium ulcerans disease. Misdiagnosis
as bacterial cellulitis can lead to delays in treatment. We report the first comprehensive descriptions of the clinical features and
risk factors of patients with oedematous disease from the Bellarine Peninsula of south-eastern Victoria, Australia.
Methods: Data on all confirmed Mycobacterium ulcerans cases managed at Barwon Health, Victoria, were collected from 1/
1/1998–31/12/2012. A multivariate logistic regression model was used to assess associations with oedematous forms of
Mycobacterium ulcerans disease.
Results: Seventeen of 238 (7%) patients had oedematous Mycobacterium ulcerans lesions. Their median age was 70 years
(IQR 17–82 years) and 71% were male. Twenty-one percent of lesions were WHO category one, 35% category two and 41%
category three. 16 (94%) patients were initially diagnosed with cellulitis and received a median 14 days (IQR 9–17 days) of
antibiotics and 65% required hospitalization prior to Mycobacterium ulcerans diagnosis. Fever was present in 50% and pain
in 87% of patients. The WCC, neutrophil count and CRP were elevated in 54%, 62% and 75% of cases respectively. The
median duration of antibiotic treatment was 84 days (IQR 67–96) and 94% of cases required surgical intervention. On
multivariable analysis, there was an increased likelihood of a lesion being oedematous if on the hand (OR 85.62, 95% CI
13.69–535.70; P,0.001), elbow (OR 7.83, 95% CI 1.39–43.96; p,0.001) or ankle (OR 7.92, 95% CI 1.28–49.16; p,0.001), or if
the patient had diabetes mellitus (OR 9.42, 95% CI 1.62–54.74; p = 0.02).
Conclusions: In an Australian population, oedematous Mycobacterium ulcerans lesions present with similar symptoms, signs
and investigation results to, and are commonly mistakenly diagnosed for, bacterial limb cellulitis. There is an increased
likelihood of oedematous lesions affecting the hand, elbow or ankle, and in patients with diabetes.
Citation: O’Brien DP, Friedman ND, McDonald A, Callan P, Hughes A, et al. (2014) Clinical Features and Risk Factors of Oedematous Mycobacterium ulcerans
Lesions in an Australian Population: Beware Cellulitis in an Endemic Area. PLoS Negl Trop Dis 8(1): e2612. doi:10.1371/journal.pntd.0002612
Editor: Richard O. Phillips, Kwame Nkrumah University of Science and Technology (KNUST) School of Medical Sciences, Ghana
Received September 23, 2013; Accepted November 14, 2013; Published January 2, 2014
Copyright:  2014 O’Brien et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors received no specific funding for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Danielo@BarwonHealth.org.au
Introduction
Oedematous lesions are a form of non-ulcerative Mycobacterium
ulcerans disease that can be rapidly progressive and cause significant
tissue damage, even despite appropriate antibiotic treatment [1,2].
They are a less common form of disease, reported to represent
0.7%–6% of cases in Benin, 3.3% of cases in northern Australia
and 15% of lesions in Ghana [3–6]. Histopathology of lesions
reveals an intact epidermis with wide contiguous coagulation
necrosis and large numbers of acid fast bacilli (AFB) in the deep
dermis, subcutaneous tissue, and fascia, with spread of AFB along
fasical planes [7]. The cause of this disease form is not known, but
it likely relates to a balance of host factors such as immune
function and organism factors such as virulence and inoculum [7].
Cases of oedematous M. ulcerans infection can be misdiagnosed as
bacterial cellulitis leading to delays in diagnosis, progression of
disease, increased morbidity and increased complexity and cost of
treatment [1,2,8]. Studies looking at the presenting clinical features
and risk factors for oedematous lesions have not been performed, yet
this information would be important to aid clinicians to diagnose
these forms early and commence appropriate treatment. To address
this information gap we have performed the first comprehensive
descriptions of the clinical features and risk factors of patients
presenting with oedematous forms of disease from a cohort of patients
from the Bellarine Peninsula of south-eastern Victoria, Australia.
Methods
Ethics statement
This is an observational cohort study, approved by Barwon
Health’s Human Research and Ethics Committee. All previously
gathered human medical data were analysed anonymously.
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Data collection
Data on all confirmed M. ulcerans cases managed at Barwon
Health, Victoria, were collected prospectively from 1/1/1998–31/
12/2012.
Case definitions
An oedematous lesion was defined as a lesion at the time of
initial presentation to the health-care provider that was manifest
by diffuse, extensive, usually non-pitting swelling with ill-defined
margins involving part or all of a limb or other part of the body
[9]. A M. ulcerans case was defined as the presence of a lesion
clinically suggestive of M. ulcerans plus any of (1) a culture of M.
ulcerans from the lesion, (2) a positive IS2404 real-time PCR from a
swab or biopsy of the lesion, or (3) histopathology of an excised
lesion showing a necrotic granulomatous ulcer with the presence of
acid-fast bacilli (AFB) consistent with acute M. ulcerans infection.
Fever was defined as a temperature $38 degrees Celsius. Immune
suppression was defined as current treatment with immunosup-
pressive medication or an active malignancy.
Statistical analysis
Data was collected using Epi-Info 6 (CDC, Atlanta) and
analysed using STATA 12 (StataCorp, Texas, USA). Proportions
were compared using 262 tables and the Chi-squared test.
Medians of non-parametric variables were compared using the
Wilcoxon rank sum test.
A logistic regression model was used to assess associations of
variables with oedematous forms of M. ulcerans. Unadjusted odds
ratios were determined by performing univariable analyses. A
multivariable analysis was performed including the variables sex
and age a priori and all variables showing strong evidence of an
association with oedematous lesions in the univariable analysis
(assessed by p#0.20). P-values were determined using the
likelihood ratio test.
Results
Overall study population
During the study period 240 patients with M. ulcerans were
managed at our health service. Two patients did not have their
type of lesion recorded and were excluded from further study.
Seventeen of 238 (7%) patients with their type of lesion recorded
had oedematous lesions. There was a trend to an increasing
proportion of oedematous cases over the study period [0/29 (0%)
cases 1998–2002, 2/61 (3%) cases 2003–2007, 15/148 (10%) cases
2008–2012; p = 0.09] (Figure 1).
Figure 1. Odematous and non-odematous Buruli ulcer cases from the Bellarine Peninsula, Australia, managed at Barwon Health
1998–2012.
doi:10.1371/journal.pntd.0002612.g001
Author Summary
The oedematous form of Buruli ulcer, caused by Mycobac-
terium ulcerans, is less common representing 7% of cases
over a 15 year period in a patient cohort from the Bellarine
Peninsula of south-eastern Victoria, Australia. In this study,
for oedematous Buruli ulcer cases, fever and pain were
usually present and investigations showed leucocytosis,
neutrophilia and a raised serum CRP. This is in contrast to
other forms of Buruli ulcer which are classically painless
and not associated with systemic symptoms. As a result
oedematous cases were usually misdiagnosed and treated
as bacterial cellulitis leading to delays in diagnosis,
progression of disease, increased morbidity and increased
complexity of treatment. Compared with non-oedematous
forms of Buruli ulcer, we found that oedematous lesions
were strongly associated with being located on the
dorsum of the hand, the elbow and the ankle, and with
patients who had diabetes mellitus. This study aims to
increase the awareness of odematous Buruli ulcer disease,
and improve the understanding of its clinical presentation
and risk factors, to aid clinicians to diagnose and treat early
Mycobacterium ulcerans infection when managing patients
with cellulitis who have been exposed to areas endemic
for Buruli ulcer.
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Patients with oedematous lesions
The median age at diagnosis for those with oedematous lesions
was 70 years (IQR 17–82 years) which was not significantly
different to those with non-oedematous lesions [57 years (IQR 38–
74); p = 0.51]. Twelve (71%) patients were male. Three patients
had diabetes, 1 of whom also had carcinoma of the prostate. The
median duration of symptoms prior to diagnosis was 20 days (IQR
15–33 days). This was significantly shorter than those with non-
oedematous lesions [42 days, (IQR 28–73); p = 0.007]. Twelve
(71%) lesions were located on the upper limb: 7 affecting the
dorsum of the hand (figure 2), 4 the elbow (figure 3) and 1 the
wrist/forearm. Five (29%) lesions were located on the lower limb:
3 affecting the ankle, 1 the toe, and 1 the knee. At diagnosis 4
(24%) lesions were classified as WHO category one, 6 (35%) as
category two and seven (41%) as category three.
16 (94%) patients were initially diagnosed with cellulitis and
received a median 14 days (IQR 9–17 days) of antibiotics for the
cellulitis prior to the diagnosis of M. ulcerans. Ten (63%) were
reported to have improved initially on antibiotic therapy. Patients
received a median of 3 different antibiotics; those used (with the
number and percent of patients where improvement was observed
in parenthesis) were: oral cephalexin (6/10; 60%), intravenous (IV)
cephazolin (8/9; 89%), IV or oral flucloxacillin/dixcloxacillin (6/
9; 67%), oral amoxicillin/clavulanic acid (0/3; 0%), IV ceftriaxone
(2/2;100%), IV vancomycin (1/2;50%), oral clindamycin (1/1;
100%), IV gentamicin (1/1; 100%) and oral doxycycline (1/1;
100%). Eleven (65%) patients required hospitalization for treat-
ment of their ‘cellulitis’. One case was misdiagnosed as an
inflammatory mass.
Fever was present in 6/12 (50%) cases in which temperatures
were measured. If elevated, the median temperature was 38.5uC
(range 37.9–39.7uC). Pain was present in 13/15 (87%) cases in
which it was reported. The WCC was elevated in 7/13 (54%) cases
in which it was available with a median WCC in these cases of
14.56109/l (range 13.2–18.86109/l). The neutrophil count was
elevated in 8/13 (62%) cases with a median value for these cases of
11.26109/l (range 8.4–4.76109/l). The CRP was elevated in 9/12
(75%) cases with a median value in these cases of 91 mg/l(IQR
27–145 mg/l). Blood cultures were negative in 8/8 (100%) of cases
in which they were collected. For the one case not misdiagnosed as
cellulitis pain but not fever was reported, and the WCC,
neutrophil count and CRP were within the normal range.
The diagnosis of Mycobacterium ulcerans was made via a swab
specimen in 9 (52%) cases (if the lesion had ulcerated) and via a
biopsy in 8 (47%) cases (when no ulceration present). When
performed, PCR was positive in 16/16 (100%) cases, AFB smear
was positive 10/12 (83%) cases and mycobacterial culture was
positive in 5/10 (50%) cases.
Figure 2. Oedematous M. ulcerans lesion dorsum of left hand.
doi:10.1371/journal.pntd.0002612.g002
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The median duration of specific antibiotic treatment for
oedematous lesions was 84 days (IQR 67–96); 13/17 (76%) had
treatment for more than 60 days. The initial antibiotic regimen
was rifampicin combined with ciprofloxacin in 11 (65%),
clarithromycin in 5 (29%) and moxifloxacin in 1 (6%) case.
Sixteen (94%) cases developed significant necrosis and required
surgical debridement, 10 (59%) required a split skin graft and 1
also required a vascularised free flap. Prednisolone was used in 5
(29%) cases to treat secondary paradoxical reactions.
All patients healed their lesions on treatment and no recurrences
were detected after 12 months of follow-up.
On multivariable analysis, there was an increased likelihood of a
lesion being oedematous if it was located on the hand (OR 85.62,
95% CI 13.69–535.70; P,0.001), elbow (OR 7.83, 95% CI 1.39–
43.96; p,0.001) or ankle (OR 7.92, 95% CI 1.28–49.16;
p,0.001), or the patient had diabetes mellitus (OR 9.42, 95%
CI 1.62–54.74; p= 0.02). (table 1) No association was found with
sex or age.
Discussion
In an Australian population, our study suggests that oedematous
lesions are usually initially misdiagnosed and treated as bacterial
cellulitis. This is not surprising as the presenting symptoms, signs
and investigations are consistent with cellulitis; fever and pain are
usually present and investigations show leucocytosis, neutrophilia
and a raised serum CRP. This is in contrast to other forms of M.
ulcerans which are classically painless and not associated with
systemic symptoms [7]. Furthermore, perhaps related to treatment
of bacterial superinfection or a degree of early immune control of
the disease, in the majority of cases health-care providers report
initial clinical improvement on antibiotic therapy targeting
cellulitis, although lesions later deteriorated. Treatment for
cellulitis leads to a delay in diagnosis, with patients receiving a
median of 2 weeks of non-M. ulcerans specific antibiotics, and
usually results in hospitalization, thereby increasing the cost and
complexity of treatment [8]. Nevertheless, the rapid progression of
lesions, and the associated pain and rapid tissue necrosis likely
results in the finding from our study that the time from onset of
symptoms until diagnosis is significantly less in oedematous
compared to non-oedematous lesions.
Our study confirms previous findings that oedematous forms of
M. ulcerans disease are less common [3–6] representing only 7% of
cases over the 15 year study period. The reasons lesions become
oedematous are unknown, but may relate to the virulence of the
infecting organism, host characteristics including their general and
local immune function, or perhaps the size and depth of the
inoculum [7]. We found that oedematous lesions were strongly
Figure 3. Oedematous M. ulcerans lesion of left elbow region showing necrosis.
doi:10.1371/journal.pntd.0002612.g003
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associated with certain positions on the body, with the dorsum of
the hands being affected 85 times more often, and the elbows and
ankles being affected 8 times more often than other parts of the
body. Reasons for this are not clear, but may include lower skin
and subcutaneous temperatures [7], reduced local immune
function or less subcutaneous tissue in these regions that may
increase the ability of the organism to spread.
In comparison, a study of African patients reported 50% of
oedematous lesions occurring on the upper limb, 38% on the lower
limb and 12% on the torso compared with 79%, 21% and 0% in
our study [5]. Of note patients in the African study had a higher
proportion of more advanced lesions (79% versus 41% with WHO
category 3 lesions), although patients in the African cohort had a
younger median age at diagnosis (11 years compared with 70 years).
As time to presentation for oedematous lesions was not reported in
the African study it was not possible to assess its impact on the
proportion of advanced lesions between the study settings [5].
Oedematous lesions can be extensive, rapidly progressive and
lead to significant tissue loss as evidenced by 76% of lesions in our
study presenting as WHO Category 2 or 3 lesions [1,4,5]. They
are characterized by the presence of large numbers of extracellular
AFBs. This suggests reduced organism inhibition by the host’s
immune system, either through organism or host factors. This is
supported in our study by the association of an increased
likelihood of oedematous lesions in patients with diabetes, likely
related to its associated immunosuppressive effects [10]. Con-
versely however, we did not find an association between
oedematous lesions and patients who were immunosuppressed.
The diagnosis of oedematous forms of MU can be hampered if
there is no ulceration as swabs of the skin surface for PCR and
AFB staining are often negative [5] and can lead to false negative
diagnoses. It is therefore important for clinicians to recognize that
other diagnostic methods are required; either a biopsy of the lesion
including subcutaneous tissue, or aspiration of the lesion which
may avoid ulceration of lesions that can occur at the biopsy site
[11].
Despite the use of appropriate antibiotics, in our experience
oedematous lesions usually ulcerate, often well into antibiotic
treatment, and require debridement +/2 skin grafting. The cause
for the ulceration on treatment is not clear but may result from
tissue swelling secondary to paradoxical reactions, which are more
common with antibiotic treatment of oedematous forms of M.
ulcerans [12], and may lead to ischaemia of skin and superficial
tissues. Another cause may be a delayed effect of persisting
mycolactone toxin [13]. It will be important to try and prevent this
late tissue loss to maximize the benefits of early treatment by
preserving involved tissue and more research needs to be
performed in this area. In our experience potential treatments
include the use of prednisolone to reduce the amount of tissue
swelling associated with paradoxical reactions [14], or subcutane-
ous tissue debridement to reduce the burden of necrotic and
inflamed tissue and potentially mycolactone toxin.
There are some potential limitations to this study. Firstly, due to
its observational design there may be other unmeasured
confounders not taken into account in the analysis of associations
with oedematous M. ulcerans lesions that could potentially affect the
Table 1. Logistic regression model showing adjusted and unadjusted associations between identified factors and oedematous
Mycobacterium ulcerans lesions.
Variable n (%) in cohort
n (%)*
oedematous
lesions Unadjusted OR (95%) p-value Adjusted OR (95% CI) p-value
Age
,15 19 (8.0) 2 (10.5) 2.97 (0.50,17.50) 0.19 2.48 (0.26,23.50) 0.62
15–60 105 (44.1) 4 (3.8) 1 1
.60 114 (47.9) 11 (9.7) 2.70 (0.83–8.75) 1.76 (0.45,6.88)
Sex
Female 116 (48.7) 5 (4.3) 1 0.09 1 0.51
Male 122 (51.3) 12 (9.8) 2.42 (0.83–7.10) 1.55 (0.42,5.63)
Diabetes
No 220 (92.4) 14 (6.4) 1 0.15 1 0.02
Yes 18 (7.6) 3 (16.7) 2.94 (0.76–11.4) 9.42 (1.62,54.74)
Immunosuppression
No 220 (3.3) 15 (6.8) 1 0.88 - -
Yes 16 (6.7) 1 (5.9) 0.86 (0.11–6.92) - -
Lesion Position
Hand 13 (5.5) 7 (53.9) 59.11 (12.18–286.83) ,0.001 85.62 (13.69–535.70) ,0.001
Elbow 34 (14.3) 4 (11.8) 6.76 (1.44–31.74) 7.83 (1.39–43.96)
Ankle 36 (15.1) 3 (8.3) 4.61 (0.89–23.84) 7.92 (1.28–49.16)
Other 155 (65.1) 3 (1.9) 1 1
Joint
No 144 (60.5) 8 (5.6) 1 0.24 - -
Yes 94 (39.5) 9 (9.6) 1.80 (0.69–4.85) - -
*Percentages represent the proportion of the variable examined from the whole cohort with that variable.
doi:10.1371/journal.pntd.0002612.t001
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validity of the findings. Observed associations should be further
studied in prospective trials. Secondly, these results are from an
Australian cohort and may not be generalisable to populations
elsewhere.
Conclusions
In an Australian population, oedematous M. ulcerans lesions
present with similar symptoms, signs and investigation results to,
and are commonly misdiagnosed as, bacterial limb cellulitis
leading to delays in their diagnosis and treatment. In patients
exposed to areas endemic for M. ulcerans, it is important for
clinicians to have a high index of suspicion of M. ulcerans in cases
presenting as cellulitis, especially if affecting the hand, elbow or
ankle, occurring in patients with diabetes, or where an adequate
response to routine antibiotics used for cellulitis has not been
achieved.
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